Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Triple Negative Breast Cancers”

618 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 618 results

Testing effectiveness (Phase 2)Study completedNCT04032080
What this trial is testing

LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Baylor Research Institute 10
Not applicableLooking for participantsNCT07073755
What this trial is testing

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Who this might be right for
Metastatic Breast CancerDrug ResistanceHormone Receptor-Positive Breast Cancer+3 more
Hunan Cancer Hospital 200
Not applicableNot Yet RecruitingNCT07191405
What this trial is testing

Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors

Who this might be right for
ImmunotherapyChemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University 156
Testing effectiveness (Phase 2)Study completedNCT02370238
What this trial is testing

Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Dompé Farmaceutici S.p.A 194
Not applicableStudy completedNCT01461044
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 228
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Not applicableEnded earlyNCT03970967
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Who this might be right for
Breast CarcinomaMetastatic Breast CancerInvasive Breast Cancer+1 more
Alpha Tau Medical LTD. 1
Large-scale testing (Phase 3)Study completedNCT01216111
What this trial is testing

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Who this might be right for
Triple Negative Breast Cancer
Fudan University 647
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Very early researchStudy completedNCT03599453
What this trial is testing

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple -Negative Breast CancerEstrogen Receptor NegativeHER2/Neu Negative+2 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00608972
What this trial is testing

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rutgers, The State University of New Jersey 31
Early research (Phase 1)UnknownNCT05957939
What this trial is testing

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Ministry of Health, Saudi Arabia 2
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Not applicableUnknownNCT05953909
What this trial is testing

Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).

Who this might be right for
Breast Cancer
Fujian Cancer Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06786026
What this trial is testing

QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
Fudan University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02393794
What this trial is testing

Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast CancerBreast Cancer
Priyanka Sharma 51
Testing effectiveness (Phase 2)Ended earlyNCT03244358
What this trial is testing

Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04445844
What this trial is testing

INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma+2 more
Mridula George, MD 25
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)UnknownNCT01732276
What this trial is testing

The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Jiangmen Central Hospital 50
Load More Results